Efficacy and Safety of Metronomic Chemotherapy Versus Palliative Hydroxyurea in Unfit Acute Myeloid Leukemia Patients: A Multicenter, Open-Label Randomized Controlled Trial

BACKGROUND: Management of unfit AML patients is a therapeutic challenge. Most hematologists tend to avoid aggressive treatment leaving patients with a choice of best supportive care. We hypothesized that metronomic chemotherapy could be an alternative treatment for unfit AML patients. METHODS: A mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Pongudom, Saranya, Phinyo, Phichayut, Chinthammitr, Yingyong, Charoenprasert, Kanyaporn, Kasyanan, Harutaya, Wongyai, Klaijith, Purattanamal, Jittiporn, Panoi, Naiyana, Surawong, Anoree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294042/
https://www.ncbi.nlm.nih.gov/pubmed/31983177
http://dx.doi.org/10.31557/APJCP.2020.21.1.147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294042/
https://www.ncbi.nlm.nih.gov/pubmed/31983177
http://dx.doi.org/10.31557/APJCP.2020.21.1.147

Ejemplares similares